目的 评估60Co陀螺刀低分割再程放疗治疗老年中晚期肝癌患者的临床价值方法 选择60Co陀螺刀首程放疗后达部分缓解,肝功能损害未加重、无恶病质倾向的老年中晚期原发性肝癌患者,根据肿瘤的位置、临床靶体积制定放疗计划,分割处方剂量为每次2.8～3.8 Gy,平均每次3 Gy；治疗次数为8～12次,平均每个周期为10次,PTV 40％～60％等剂量线内边缘总放射剂量为22.4～45.5 Gy,每天一次.
Objective Gastric cancer (GC) is a diffuse disease with extensively poor prognosis.To guide clinicians in selecting treatment options for GC patients, reliable markers predictive of poor clinical outc
Objective: To investigate the feasibility and efficacy of consolidation chemotherapy of ovary and oviduct malignant epithelial tumors.Method We have retrospectively analysised eight patients who had b
Objective We aimed to evaluate the effectiveness and safety of intravenous (Ⅳ) plus intraperitoneal (IP) chemotherapy compared to intravenous (Ⅳ) chemotherapy alone for patients with gastric cancer.Me
Objective Metaplastic breast carcinoma (MBC) is a rare heterogeneous group of primary breast malignancies, and has low hormone receptor expression and poor outcomes.As so far, no prognostic markers fo
患者,男,30岁,眼部检查:右眼视力为1.0,左眼为1.0.右眼球向前方突出.Hertel眼球突出计测量:右眼为20.5 mm,左眼为14.0 mm,眶距为100 mm.右眶内眼球颞侧可触及肿物前极,质硬,不能推动.下睑内翻,睫毛触及角膜,球结膜混合充血,高度水肿.巩膜无黄染,角膜透明,前房深浅可,房水闪辉(-),虹膜纹理清楚,瞳孔圆形,直径约3mm,直接和间接对光反射灵敏,晶状体透明,玻璃体清晰
Objective To evaluate the value of combined detection of serum carcinoembryonic antigen (CEA),cytokeratin 19 fragment (CYFRA21-1), and carbohydrateantigen 125 (CA125) for the clinical diagnosis of non
目的 依据小分子吲哚菁绿中的含硫活性基团能与大分子利妥昔单抗中的自由氨基相结合(主要为赖氨酸的ε-氨基)的偶联反应原理，制备新型前哨淋巴结示踪剂吲哚菁绿-利妥昔单抗，并对其体外特性及体内应用的安全性进行评价.方法 在室温、中性环境条件下，使用10 mg/ml利妥昔单抗溶液与2.5 mg/ml吲哚菁绿溶液，将利妥昔单抗和吲哚菁绿按4∶1的质量比混匀，通过直接偶联反应制备吲哚菁绿-利妥昔单抗偶联物，之
Objective Granular cell tumors (GCT) are uncommon, and usually benign neoplasms most commonly originated from tongue, skin, and breast.Malignant granular cell tumor (MGCT) which originally occurs in t
目的 环氧合酶(cyclooxygenase,COX)是合成前列腺素(PG)过程中的一个重要的限速酶,有COX-1、COX-2和COX-3三种异构体。近年来的研究表明,COX-2与多种肿瘤的发生、发展有着密切关系,COX-2在多种肿瘤细胞中有高水平的表达。本研究探讨COX-2在结肠癌中的表达情况及其相关意义,即COX-2在结肠癌的发生、发展中的作用,以为结肠癌的防治和判断预后提供理论依据。